Priti Patel

Insider Reports History

Entity
Individual
Location
C/O Neoleukin Therapeutics, Inc., 188 East Blaine Street, #450, Seattle, WA
Signature
/s/ Sean Smith, as Attorney-in-Fact for Priti Patel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Priti Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Former Chief Medical Officer Common Stock 37.3K $25.9K $0.69 Apr 3, 2023 Direct
Neoleukin Therapeutics, Inc. Former Chief Medical Officer Stock Option (Right to Buy) 250K Aug 2, 2022 Direct
Neoleukin Therapeutics, Inc. Former Chief Medical Officer Restricted Stock Units 0 Mar 31, 2023 Direct

Insider Reports Filed by Priti Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. Mar 31, 2023 3 -$2.61K 4 Apr 4, 2023 Former Chief Medical Officer
NLTX Neoleukin Therapeutics, Inc. Feb 1, 2023 3 -$8.59K 4 Feb 3, 2023 Chief Medical Officer
NLTX Neoleukin Therapeutics, Inc. Aug 2, 2022 1 $0 4 Aug 4, 2022 Chief Medical Officer
NLTX Neoleukin Therapeutics, Inc. Apr 30, 2022 3 -$6.75K 4 May 3, 2022 Chief Medical Officer
NLTX Neoleukin Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Chief Medical Officer
NLTX Neoleukin Therapeutics, Inc. Aug 3, 2021 1 $0 4 Aug 5, 2021 Chief Medical Officer